Follistatin-344
A synthetic follistatin variant studied in myostatin inhibition, muscle-cell growth, strength-related signaling, tissue regeneration, and growth-factor regulation.
Organized for coordinated study of muscle-growth signaling, GH and IGF-1 pathways, and tissue-repair response.

Follistatin-344 supplies a myostatin-focused research pathway. Tesamorelin and CJC-1295 add growth-hormone and IGF-1 signaling, while TB-500 adds cell migration, angiogenesis, collagen deposition, and tissue-remodeling models.
Follistatin-344 · Tesamorelin · CJC-1295 · TB-500
The complete component notes below are adapted from the client-supplied protocol worksheet and framed for laboratory research.
A synthetic follistatin variant studied in myostatin inhibition, muscle-cell growth, strength-related signaling, tissue regeneration, and growth-factor regulation.
A growth-hormone-releasing hormone analogue studied in growth-hormone, IGF-1, lipid-metabolism, and cognitive-signaling models.
A growth-hormone-releasing hormone analogue investigated in growth-hormone and IGF-1 signaling, metabolic, sleep, tissue-response, and skin-biology models.
A thymosin beta-4-related analogue studied in cell migration, angiogenesis, collagen deposition, inflammatory signaling, and tissue remodeling.
This reference explains why the compounds are grouped and identifies the biological pathways represented by the stack. It does not prescribe concentration, sequence, frequency, compatibility, preparation, or administration.
Qualified researchers are responsible for independent literature review, experimental design, controls, handling procedures, documentation review, and compliance with all applicable requirements.
4-compound research set · $204.00
VIEW STACK & ADD TO CART →All information on this page describes laboratory research pathways only. Products are not intended for human or veterinary use and are not offered to diagnose, treat, cure, or prevent any disease.